Canhelp® Origin

Canhelp® – Origin Diagnostic Test for Identifying the Origin of Tumor Utility of Canhelp-Origin Canhelp-Origin is a molecular test used on FFPE tumor tissue samples to identify the primary site of a metastatic tumor,...

Canhelp®-UriBLAD

Canhelp®-UriBLAD CE-IVD Diagnostic Test for the Detection of Urothelial Cancer Utility of Canhelp-UriBLAD Current guidelines for urothelial carcinoma support a diagnostic approach based on cystoscopy combined with sample urine cytology....

BiomeOne®

BiomeOne® Microbiota Analysis for Immunotherapy The first test to support the prediction of the response to cancer immunotherapy based on the microbiota What is BiomeOne? BiomeOne is the first CE-IVD test on fecal sample that can provide support in the...

MyRisk® Plus

MyRisk® Plus Multigene Germline Test for Hereditary Cancer How does MyRisk Plus help? MyRisk is a multigene germline blood test that can help determine a patient’s hereditary cancer risk by focusing on eleven of the most common cancers...

MyChoice®CDx PLUS

MyChoice®CDx PLUS HRD Test on Tumor Tissue Determination of Homologous Recombination Deficiency (HRD) in Ovarian Cancer MyChoice CDx Plus is a genomic test that guides medical decisions in the treatment of ovarian cancer with PARP-inhibitors. The test is...

Prolaris®

Prolaris® Prostate Cancer Genomic Test How Prolaris is useful Prolaris is a prognostic genomic test for prostate cancer, developed to help healthcare professionals predict the aggressiveness of the tumor. Prolaris is indicated for patients who have...
This website contains information on medical-diagnostic products reserved for healthcare professionals, in accordance with current legislation. Are you a healthcare professional?
This website contains information on medical diagnostic products intended for healthcare professionals. Click the left button to continue if you are a healthcare professional, or the right button to exit if you are not.